Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Mister Spex Aktie 112250364 / DE000A3CSAE2

30.10.2025 07:31:43

EQS-News: Mister Spex appoints Benjamin v. Schenck as Chief Financial Officer

EQS-News: Mister Spex SE / Key word(s): Personnel/Miscellaneous
Mister Spex appoints Benjamin v. Schenck as Chief Financial Officer

30.10.2025 / 07:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


Mister Spex appoints Benjamin v. Schenck as Chief Financial Officer  

Mister Spex SE today announced the appointment of Benjamin v. Schenck as Chief Financial Officer and member of the Management Board, effective 1 November 2025.

Benjamin brings more than 15 years of finance and leadership experience across digital, retail and media sectors. Most recently, he served as CFO at Outfittery, where he guided the company through a demanding business environment and its merger with Lookiero. Before that, he held several senior finance positions at ProSiebenSat.1 Media SE, where he helped shape the Group’s digital and advertising-platform businesses, led key integration initiatives, and contributed to strategic transactions. He started his career in investment banking at BNP Paribas in Frankfurt and Paris.

Tobias Krauss, CEO of Mister Spex SE, commented: “We are delighted to welcome Benjamin to Mister Spex. His broad Finance expertise, operational mindset, and proven track record in managing transformation and integration make him an excellent fit for our next chapter. As we start shifting focus toward disciplined growth and profitability, Benjamin will play a key role in strengthening our financial steering and driving profitable growth”.

Nicola Brandolese, Chairman of the Supervisory Board of Mister Spex SE: “Benjamin’s appointment marks another important step in reinforcing the leadership team for the next phase of Mister Spex’s transformation. His experience across digital platforms will add valuable perspective as the company continues to build scale and deliver on its long-term value creation ambitions”.

Benjamin v. Schenck added: “Mister Spex combines a strong brand with a distinctive omnichannel model and clear potential for value creation. I’m excited to join at this stage of the journey and to help drive the next phase of the company’s strategic and financial transformation”.

Benjamin v. Schenck succeeds Stephan Schulz-Gohritz, who will leave the company by mutual agreement on October 31, 2025.

 


 

About Mister Spex SE:

Mister Spex is one of Germany’s leading optical retailers, distinguished by its seamless integration of online and offline presence, innovative technologies, a comprehensive product range, and exceptional customer service. Since its founding in 2007, Mister Spex has evolved from a pure online player into a successful omnichannel optician, serving over 8 million customers and four online shops across Europe as well as 65 own retail stores in Germany. Mister Spex employs over 120 highly qualified opticians who ensure top-notch optical services in their stores. As a digital native, technology and innovation have always been central to the company’s development. Utilizing advanced technologies such as digital 2D-to-3D tools for frame adjustment and intelligent browsing functionalities, Mister Spex sets new standards in the optics industry, offering extraordinary value to its customers. Mister Spex focuses on making the eyewear purchasing experience unique, simple, transparent, and enjoyable, combining a wide and diverse range of high-quality products with extensive optical expertise and advice through customer service, its own stores, and an extensive network of partner opticians.

 

 

 

Investor Relations:

Irina Zhurba I Director of Investor Relations I irina.zhurba@misterspex.de

Press Contact:
Elina Schneiders I Head of Corporate Communications | Elina.schneiders@misterspex.de

 

 

 

Mister Spex SE 

Hermann-Blankenstein-Strasse 24
D-10249 Berlin
Website: www.misterspex.de  
Corporate Website: https://corporate.misterspex.com



30.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Mister Spex SE
Hermann-Blankenstein-Strasse 24
10249 Berlin
Germany
E-mail: presse@misterspex.de
Internet: www.misterspex.de
ISIN: DE000A3CSAE2
WKN: A3CSAE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2220714

 
End of News EQS News Service

2220714  30.10.2025 CET/CEST

Analysen zu Mister Spex

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’821.95 19.72 S2S3YU
Short 13’093.54 13.71 UEBSLU
Short 13’578.71 8.95 UIDBSU
SMI-Kurs: 12’301.21 30.10.2025 17:30:00
Long 11’737.17 18.56 SHFB5U
Long 11’508.22 13.79 BBWS3U
Long 11’009.08 8.95 BSXSZU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com